Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
Contents:; Cellular mechanisms of chemotherapy -- Pharmacologic principles of chemotherapy -- Pharmacogenomics and chemotherapy -- Principles and standards of antineoplastic therapy administration -- Administration of hazardous drugs in the perioperative setting -- Immunotherapy : agents and target…
Contents:; 1: Basis of Carcinogenesis; 2: Epidemiology and Prevention; 3: Evidence-Based Nursing in Basic Anticancer Treatment: Management of the Most Important Side Effects; 4: The Patients? Journey with Targeted Therapies; 5: Immunotherapy: New Challenges for Nursing; 6: Robotic Surgery; 7: Relat…
Contents:; Physical activity and cancer survival -- Promoting physical activity for cancer survivors -- FITT principle for physical activity -- Assessing readiness for physical activity -- Assessing readiness for physical activity : physical -- Considerations -- Evaluating tolerance and adherence t…
Overview; Diagnostic studies; Neurologic symptoms; Direct complications of cancer; Indirect complications of cancer; Complications of cancer therapy; Neurologic complications of specific malignancies
Management of dyspnea; Skeletal metastases : optimal management today; Cancer pain; Anorexia and cachexia; Fatigue; Pathogenesis and management of venous; Thromboembolism in cancer patients; Depression in cancer patients; Anemia; Neutropenia; Nausea and nomiting; Oral mucositis; Diarrhea and consti…
Version 4.0 published: May 28, 2009 (v4.03: June14, 2010)."
Table of contents:; History of Cancer Immunotherapy -- Section I: Basic Principles of Tumor Immunology -- Section II: Cancer Immunotherapy Targets and Classes -- Section III: Immune Function in Cancer Patients -- Section IV: Disease-Specific Treatments and Outcomes -- Section V: Regulatory Aspects …
Table of Contents:; Chapter 1 -- Translation in Immunology: The Role of Translational Biomarkers to Guide Clinical Use of Immunotherapy for Cancer -- Chapter 2 Monoclonal Antibody Therapy -- Chapter 3 Somatic Mutations and Immunotherapy -- Chapter 4 Checkpoint Blockade -- Chapter 5 Myeloid Leukemia…